Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6527
    +0.0027 (+0.41%)
     
  • OIL

    82.81
    0.00 (0.00%)
     
  • GOLD

    2,337.30
    -1.10 (-0.05%)
     
  • Bitcoin AUD

    97,746.78
    -3,895.20 (-3.83%)
     
  • CMC Crypto 200

    1,361.60
    -20.97 (-1.52%)
     
  • AUD/EUR

    0.6083
    +0.0012 (+0.20%)
     
  • AUD/NZD

    1.0954
    +0.0012 (+0.11%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,093.80
    +53.42 (+0.66%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    17,980.41
    -108.29 (-0.60%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Is Abiomed Stock a Buy?

Is Abiomed Stock a Buy?

Abiomed (NASDAQ: ABMD) struggled in 2019, but the stock has risen more than 62% so far this year. Abiomed's devices all have to do with the circulatory system, including the world's smallest heart pump, the Impella. Since the company acquired the Impella technology by buying German company Impella CardioSystems in 2005, Abiomed's revenue has risen every year.